GWM
GILD icon

Gitterman Wealth Management’s Gilead Sciences GILD Stock Holding History

Gitterman Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,551
Closed -$172K – 206
2025
Q2 		$172K Buy
+1,551
New +$165K 0.04% 173

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Gitterman Wealth Management's GILD Position: Q3 2025 in Review

Gitterman Wealth Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 1,551 shares — an estimated $172K sold.

Gitterman Wealth Management first reported a position in GILD in Q2 2025 and held it in 1 quarter. The position peaked at $172K in Q2 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Gitterman Wealth Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Gitterman Wealth Management sold 1,551 Gilead Sciences shares in Q3 2025, an estimated $172K.
  • Gitterman Wealth Management first reported a position in Gilead Sciences in Q2 2025 and held it in 1 quarter.
  • Gitterman Wealth Management's Gilead Sciences position peaked at $172K in Q2 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Gitterman Wealth Management's 13F filing for Q3 2025, filed 4 Nov 2025.